Literature DB >> 7124763

Legionnaires' disease: new clinical perspective from a prospective pneumonia study.

V L Yu, F J Kroboth, J Shonnard, A Brown, S McDearman, M Magnussen.   

Abstract

In an attempt to ascertain the incidence of Legionnaires' disease at our hospital, a prospective case-control pneumonia study was conducted for 11 months. Specialized diagnostic tests for Legionella pneumophila, including serologic study, direct immunofluorescent examination, and selective culture, were made routinely available in our hospital. To our surprise, L. pneumophila was the most common cause of pneumonia (22.5 percent) attributable to a single pathogen, followed by Streptococcus pneumoniae (10.6 percent). In 68.8 percent of the cases, Legionnaires' pneumonia was hospital-acquired. In contrast to other investigators, we found that abdominal pain, diarrhea, neurologic signs, abnormal liver function results, hypophosphatemia, and hematuria did not occur significantly more frequently in pneumonia caused by L. pneumophila than in that caused by other microorganisms. However, hyponatremia within five days of onset of pneumonia occurred significantly more frequently in Legionnaires' disease (p less than 0.0001). Since the clinical presentation is nonspecific, specialized laboratory tests are necessary to make the diagnosis. As a result of our experience, we suggest an approach using serologic tests as a screen to determine whether more specialized tests for Legionnaires' disease should be introduced into a hospital without previously recognized cases of Legionnaires' disease.

Entities:  

Mesh:

Year:  1982        PMID: 7124763

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

1.  A new category--healthcare-associated pneumonia: a good idea, but problems with its execution.

Authors:  S Fujitani; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

2.  Radiographic appearance of nosocomial legionnaires' disease after erythromycin treatment.

Authors:  C Domingo; J Roig; F Planas; J Bechini; M Tenesa; J Morera
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

3.  Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.

Authors:  Rosa Bellmann-Weiler; Mathias Ausserwinkler; Katharina Kurz; Igor Theurl; Guenter Weiss
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

4.  Discovery of occult legionella pneumonia in a long stay hospital: results of prospective serological survey.

Authors:  C Brennen; R M Vickers; V L Yu; A Puntereri; Y C Yee
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Fatal legionellosis in patients with malignant hematologic diseases.

Authors:  D Schürmann; B Ruf; F Pfannkuch; I Horbach; H D Pohle
Journal:  Blut       Date:  1988-01

6.  Legionnaires' disease: a review of 79 community acquired cases in Nottingham.

Authors:  M A Woodhead; J T Macfarlane
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

7.  Treatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila.

Authors:  J A Elliott; W C Winn
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 8.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

9.  Effect of immunosuppressive therapy on the clinical presentation of legionellosis.

Authors:  K Skogberg; P Ruutu; I Koivula; H Jousimies-Somer; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 10.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.